Efficacy trial of 4 weeks ingestion of the development code MSHF001
- Conditions
- Healthy adults
- Registration Number
- JPRN-UMIN000033191
- Lead Sponsor
- Kao Corporation
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- Female
- Target Recruitment
- 20
Not provided
-Subjects with systemic illness -Subjects who regularly take medicine. -Subjects who are outpatients or were treated by doctor within a month. -Subjects who are under Hormone Replacement Therapy, HRT, and/or medication which would affect blood hormone levels. -Subjects who are pregnant or lactating, or planned to become pregnant in the near future. -Subjects with smoking habit. -Subjects with drinking habit in 4 or more days a week. -Subjects who have possibilities for emerging allergy to foods, metals, and drugs. -Subjects who easily have skin rashes. -Subjects with potential conflict of interest. -Subjects who plan to participate in other clinical trials during this study. -Subjects who are judged to be inappropriate for this study by the investigator for other reason.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method